These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17476281)

  • 1. Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies.
    Guillem VM; Collado M; Terol MJ; Calasanz MJ; Esteve J; Gonzalez M; Sanzo C; Nomdedeu J; Bolufer P; Lluch A; Tormo M
    Leukemia; 2007 Jul; 21(7):1413-22. PubMed ID: 17476281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
    Haase D; Hanf V; Schulz T
    Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in DNA repair and metabolic genes in bladder cancer.
    Sanyal S; Festa F; Sakano S; Zhang Z; Steineck G; Norming U; Wijkström H; Larsson P; Kumar R; Hemminki K
    Carcinogenesis; 2004 May; 25(5):729-34. PubMed ID: 14688016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from the Czech Republic.
    Pardini B; Kumar R; Naccarati A; Prasad RB; Forsti A; Polakova V; Vodickova L; Novotny J; Hemminki K; Vodicka P
    Mutat Res; 2011 Mar; 721(1):74-80. PubMed ID: 21211571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia.
    Nückel H; Frey UH; Dürig J; Dührsen U; Siffert W
    Leukemia; 2004 Nov; 18(11):1816-23. PubMed ID: 15385937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation.
    Terrazzino S; Agostini M; Pucciarelli S; Pasetto LM; Friso ML; Ambrosi A; Lisi V; Leon A; Lise M; Nitti D
    Pharmacogenet Genomics; 2006 Nov; 16(11):817-24. PubMed ID: 17047490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
    Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
    J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies.
    Kim HN; Kim YK; Lee IK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Park MR; Jo DY; Won JH; Kwak JY; Kim HJ
    Leuk Res; 2009 Jan; 33(1):82-7. PubMed ID: 18774170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of secondary leukemias.
    Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
    Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTHFR 677C-->T and 1298A-->C polymorphisms in children with Down syndrome and acute myeloid leukemia in Brazil.
    Amorim MR; Zanrosso CW; Magalhães IQ; Pereira SC; Figueiredo A; Emerenciano M; Pinheiro VR; d'Andréa ML; Orioli IM; Koifman S; Pombo-de-Oliveira MS
    Pediatr Hematol Oncol; 2008 Dec; 25(8):744-50. PubMed ID: 19065440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk.
    Ziva Cerne J; Stegel V; Gersak K; Novakovic S
    Mol Med Rep; 2011; 4(1):175-9. PubMed ID: 21461582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study.
    Karagas MR; Park S; Nelson HH; Andrew AS; Mott L; Schned A; Kelsey KT
    Int J Hyg Environ Health; 2005; 208(5):321-7. PubMed ID: 16217917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase gene polymorphisms and risk of acute lymphoblastic leukemia in children.
    Sadananda Adiga MN; Chandy S; Ramachandra N; Appaji L; Aruna Kumari BS; Ramaswamy G; Savithri HS; Krishnamoorthy L
    Indian J Cancer; 2010; 47(1):40-5. PubMed ID: 20071789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and susceptibility to therapy-related myeloid neoplasms.
    Leone G; Fianchi L; Pagano L; Voso MT
    Chem Biol Interact; 2010 Mar; 184(1-2):39-45. PubMed ID: 20026017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
    Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
    Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population.
    Schnakenberg E; Mehles A; Cario G; Rehe K; Seidemann K; Schlegelberger B; Elsner HA; Welte KH; Schrappe M; Stanulla M
    BMC Med Genet; 2005 May; 6():23. PubMed ID: 15921520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.
    Bolufer P; Collado M; Barragan E; Calasanz MJ; Colomer D; Tormo M; González M; Brunet S; Batlle M; Cervera J; Sanz MA
    Br J Haematol; 2007 Feb; 136(4):590-6. PubMed ID: 17367411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of DNA damage and repair upon the risk of treatment related leukemia.
    Guillem V; Tormo M
    Leuk Lymphoma; 2008 Feb; 49(2):204-17. PubMed ID: 18231906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
    Lin J; Spitz MR; Wang Y; Schabath MB; Gorlov IP; Hernandez LM; Pillow PC; Grossman HB; Wu X
    Carcinogenesis; 2004 Sep; 25(9):1639-47. PubMed ID: 15117811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylenetetrahydrofolate reductase gene polymorphisms c.677C/T and c.1298A/C are not associated with open angle glaucoma.
    Mabuchi F; Tang S; Kashiwagi K; Yamagata Z; Iijima H; Tsukahara S
    Mol Vis; 2006 Jul; 12():735-9. PubMed ID: 16862068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.